These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33595329)
1. Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues. Hammid A; Fallon JK; Lassila T; Salluce G; Smith PC; Tolonen A; Sauer A; Urtti A; Honkakoski P Mol Pharm; 2021 Mar; 18(3):1305-1316. PubMed ID: 33595329 [TBL] [Abstract][Full Text] [Related]
2. Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues. Hammid A; Fallon JK; Lassila T; Vieiro P; Balla A; Gonzalez F; Urtti A; Smith PC; Tolonen A; Honkakoski P Drug Metab Dispos; 2022 Dec; 50(12):1483-1492. PubMed ID: 36195336 [TBL] [Abstract][Full Text] [Related]
3. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans. Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098 [TBL] [Abstract][Full Text] [Related]
4. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases. Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127 [TBL] [Abstract][Full Text] [Related]
5. Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells. Gabriele M; Puccini P; Gervasi PG; Longo V Life Sci; 2021 Jul; 277():119486. PubMed ID: 33864822 [TBL] [Abstract][Full Text] [Related]
6. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung. Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485 [TBL] [Abstract][Full Text] [Related]
7. Esterase activity in porcine and albino rabbit ocular tissues. Heikkinen EM; Del Amo EM; Ranta VP; Urtti A; Vellonen KS; Ruponen M Eur J Pharm Sci; 2018 Oct; 123():106-110. PubMed ID: 30030098 [TBL] [Abstract][Full Text] [Related]
8. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase. Shimizu M; Fukami T; Nakajima M; Yokoi T Drug Metab Dispos; 2014 Jul; 42(7):1103-9. PubMed ID: 24751575 [TBL] [Abstract][Full Text] [Related]
9. Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology. Nagaoka M; Sakai Y; Nakajima M; Fukami T Biochem Pharmacol; 2024 May; 223():116128. PubMed ID: 38492781 [TBL] [Abstract][Full Text] [Related]
10. Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans. Honda S; Fukami T; Hirosawa K; Tsujiguchi T; Zhang Y; Nakano M; Uehara S; Uno Y; Yamazaki H; Nakajima M Drug Metab Dispos; 2021 Sep; 49(9):718-728. PubMed ID: 34135089 [TBL] [Abstract][Full Text] [Related]
11. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA. Fu J; Sadgrove M; Marson L; Jay M Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352 [TBL] [Abstract][Full Text] [Related]
12. Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase. Yasuda K; Watanabe K; Fukami T; Nakashima S; Ikushiro SI; Nakajima M; Sakaki T Drug Metab Pharmacokinet; 2021 Aug; 39():100397. PubMed ID: 34171773 [TBL] [Abstract][Full Text] [Related]
13. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2. Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359 [TBL] [Abstract][Full Text] [Related]
14. New insight on porcine carboxylesterases expression and activity in lung tissues. Cavallero A; Donadel G; Puccini P; Gervasi PG; Gabisonia K; Longo V; Gabriele M Res Vet Sci; 2024 Aug; 175():105314. PubMed ID: 38823354 [TBL] [Abstract][Full Text] [Related]
15. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors. Thomsen R; Rasmussen HB; Linnet K; Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856 [TBL] [Abstract][Full Text] [Related]
16. Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver. Kobayashi Y; Fukami T; Shimizu M; Nakajima M; Yokoi T Drug Metab Dispos; 2012 Jun; 40(6):1080-4. PubMed ID: 22446520 [TBL] [Abstract][Full Text] [Related]
17. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver. Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802 [TBL] [Abstract][Full Text] [Related]
18. Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC. Honda S; Fukami T; Tsujiguchi T; Zhang Y; Nakano M; Nakajima M Eur J Pharm Sci; 2021 Jun; 161():105807. PubMed ID: 33722734 [TBL] [Abstract][Full Text] [Related]
19. Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog. Kurokawa T; Fukami T; Yoshida T; Nakajima M Drug Metab Dispos; 2016 Mar; 44(3):409-16. PubMed ID: 26718653 [TBL] [Abstract][Full Text] [Related]
20. [Hydrolysis by carboxylesterase and disposition of prodrug with ester moiety]. Imai T Yakugaku Zasshi; 2007 Apr; 127(4):611-9. PubMed ID: 17409690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]